Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nepentes is a Polish pharmaceutical company specializing in the development, manufacturing, and marketing of dermocosmetics and over-the-counter (OTC) drug products. Founded in 1991, the company established a strong market presence in Central and Eastern Europe with flagship brands such as Iwostin and Emolium, which target sensitive and problematic skin conditions. In 2010, Nepentes was acquired by Sanofi to strengthen its consumer healthcare portfolio in the region. The company's product range includes treatments for atopic dermatitis, acne, and daily skincare, supported by clinical research and dermatological testing. Today, its brands continue to operate under the Sanofi umbrella, maintaining a focus on pharmacy-distributed healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nepentes.